CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +8,974 | $1.11 | $10K | 16,588 |
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −8,974 | $6.07 | $54K | 7,614 |
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +10,741 | $1.72 | $18K | 18,355 |
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −10,741 | $6.07 | $65K | 7,614 |
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −8,914 | 39,786 | ||
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −8,974 | 39,766 | ||
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −10,741 | 53,009 | ||
| 2025-11-03 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +1,300 | $2.39 | $3K | 833,892 |
| 2025-11-03 | LEWIS JOEL President and CEO | Sale 10b5-1 | −1,300 | $6.01 | $8K | 832,592 |
| 2025-11-03 | LEWIS JOEL President and CEO | Option exercise · Stock option (right to buy) 10b5-1 | −1,300 | 38,950 | ||
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +1,300 | $1.98 | $3K | 8,914 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −1,300 | $6.01 | $8K | 7,614 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +1,260 | $1.11 | $1K | 8,874 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −1,260 | $6.01 | $8K | 7,614 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +1,250 | $1.72 | $2K | 8,864 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −1,250 | $6.01 | $8K | 7,614 |
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,300 | 48,700 | ||
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,260 | 48,740 | ||
| 2025-11-03 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,250 | 63,750 | ||
| 2025-10-22 | 10X Fund, L.P. 10% owner | Sale | −20,000 | $4.93 | $99K | 5,902,207 |
Page 10 of 15 · 291 trades